INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026

manilatimes.net · 2026-10-27

SARASOTA, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. ('INVO”) (NASDAQ: IVF), a healthcare company focused on the establishment, acquisition and operation of fertility clinics and related businesses and technologies, announced today that it will effect a 1-for-4 reverse split of its issued and outstanding and of its authorized common stock effective as of 12:01 a.m. Eastern Time on October 30, 2026. Commencing with the opening of trading on The Nasdaq Capital Market on October 30, 2026, the Company’s common stock will trade on a post-split basis under the same trading symbol, 'IVF”.

TickrTrends take: HCSG operates in the Healthcare sector where corporate restructuring actions like reverse stock splits can signal various operational or financial pressures. Given that TickrTrends currently rates HCSG as overvalued, investors should monitor whether similar capital structure changes might occur in comparable healthcare companies, as such moves can reflect underlying challenges that may not be immediately apparent in traditional valuation metrics. Healthcare sector participants facing valuation pressures warrant attention to their capital management decisions, as these often precede shifts in investor sentiment or earnings trajectories.

Read the full story at manilatimes.net →